ArticleHealth science reports2025
The Cancer Burden in Sarawak, Malaysia: Sarawak Cancer Report.
Article in Health science reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Breast cancer survival rates in Sarawak, Malaysia: a central referral centre study.BMC cancer · 2026Article
- Immunotherapy in Asia: current insights and prospects in Southeast Asia and Malaysia.Frontiers in oncology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Malaysia, like many developing countries, is undergoing epidemiologic transition where non-communicable diseases, including cancer, are emerging as a prevalent health burden. Sarawak is the largest state in Malaysia, located on the island of Borneo. Compiling region-specific cancer statistics is crucial for future planning and implementation of effective cancer management strategies. Methods: This study utilized cancer data reported to the Sarawak State Health Department with a cancer notification form. Data was obtained from the State cancer database. Incidence, Age-Standardized Rate, frequency, cumulative rate, and lifetime risk were calculated. The population included Sarawak residents only who were defined as Malaysian citizens as well as permanent residents living in Sarawak at the time of diagnosis. Results: Between years 2011-2015, there were a total of 10,320 cancer cases (47.3% male). The incidence rate was approximately 16.6 persons per 100,000 population per year. An increasing trend was observed in cancer incidence with increasing age. Ethnic distribution reported the highest incidence among the Chinese (male cases:36.2% and female cases:36.4%), followed by the Iban (male cases:26.9% and female cases:24.5%), and Malay (male cases:18.3% and female cases:22.0%). The three most common cancers in male were colorectal (15.4%), nasopharyngeal (14.8%), and trachea, bronchus, lung (14.0%) cancer. In females, the first three common cancers were breast (27.9%), cervix uteri (11.6%), and colorectal (9.8%). There were wide disparities among common cancers across genders, different age groups and ethnic groups. Conclusion: The lifetime risk of a Sarawakian to develop cancer by age 75 is 1 in 11 in females and 1 in 10 in males. This present study provided a framework for the status and trend of cancer in Sarawak. These findings will provide additional information to guide strategy and resource planning in improving cancer care in Sarawak.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.